Two years ago the shares were riding at 635p on the group's TB development. As hopes faded they plunged to a 61.5p low.
We are currently trialling our new-look independent.co.uk website - please send any feedback to email@example.com
STANDFORD ROOK, the little biotech company, jumped 24p to 166.5p, its highest for more than a year. Talk of a forthcoming link with a major pharmaceuticals group with an asthma treatment was behind the surge.